[1]
2021. Evaluating the Sensitivity of (miR-378) as a Circulatory Screening Biomarker for Diabetic Cardiomyopathy: Comparative Study. Medico Legal Update. 21, 1 (Jan. 2021), 912–918. DOI:https://doi.org/10.37506/mlu.v21i1.2432.